在胰腺β细胞中,NMDA通过MEK/ERK/LXR通路抑制胰腺ABCA1表达

Takanobu Saheki1, Hitomi Imachi1, Kensaku Fukunaga1

  • 1Department of Endocrinology and Metabolism, Faculty of Medicine, Kagawa University, 1750-1, Ikenobe, Miki-cho, Kita-gun 761-0793, Japan.

Nutrients
|September 14, 2024
PubMed
概括

N-甲基-D-酸 (NMDA) 通过MEK/ERK/LXR通路抑制胰腺β细胞中ATP结合盒载体A1 (ABCA1) 的表达. 这种机制会损害胰岛素分泌和葡萄糖调节,导致2型糖尿病的发病.